|
Market Closed -
Nasdaq Stockholm
09:30:00 28/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1.810 SEK | +0.56% |
|
-2.69% | -4.74% |
| 27/08 | Enzymatica expands group management with two executives | FW |
| 20/07 | Enzymatica CFO Holger Lembrér buys shares for 110,000 kronor | FW |
| Market Cap | 44Cr 38Cr 35Cr 32Cr 61Cr 4.2TCr 61Cr 421.14Cr 164.31Cr 2.12TCr 164.95Cr 161.36Cr 7.03TCr | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 41Cr 35Cr 33Cr 30Cr 57Cr 3.89TCr 57Cr 390.36Cr 152.3Cr 1.96TCr 152.9Cr 149.57Cr 6.51TCr | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.56% | ||
| 1 week | -2.69% | ||
| Current month | -2.43% | ||
| 1 month | -1.90% | ||
| 3 months | -33.21% | ||
| 6 months | -7.65% | ||
| Current year | -4.74% |
| 1 week | 1.65 |  | 1.92 |
| 1 month | 1.65 | | 2.1 |
| Current year | 1.6 | | 3.4 |
| 1 year | 1.6 | | 3.4 |
| 3 years | 1.34 | | 5.45 |
| 5 years | 1.34 | | 12 |
| 10 years | 1.34 | | 24.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 01/02/2026 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 13/04/2026 |
| Chief Tech/Sci/R&D Officer | - | 27/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 15/02/2016 | |
Bengt Baron
CHM | Chairman | 64 | 19/12/2016 |
| Director/Board Member | 71 | 19/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/07/26 | Buy | Chief Financial Officer | 50,000 | 0.0206% | ||
| 01/04/26 | Sell | Responsable ventes & marketing | 40,000 | 0.0165% | ||
| 30/12/25 | Buy | Chairman | 20,000 | 0.0082% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.56% | -2.69% | -23.95% | -33.46% | 4.58Cr | |
| -0.13% | -6.44% | +60.47% | +112.05% | 1,04700Cr | |
| +0.85% | -0.81% | +52.77% | +63.15% | 65TCr | |
| -1.03% | -3.58% | +22.87% | +73.29% | 45TCr | |
| -1.46% | -4.50% | +37.43% | +38.41% | 35TCr | |
| -0.72% | -2.89% | +21.86% | +36.79% | 29TCr | |
| -1.19% | -2.21% | +1.35% | +12.29% | 25TCr | |
| -1.05% | -1.57% | +51.40% | +68.55% | 23TCr | |
| +0.08% | -1.78% | -17.64% | -54.29% | 20TCr | |
| -2.14% | -0.30% | +29.42% | +89.10% | 18TCr | |
| Average | -0.63% | -2.68% | +23.60% | +40.59% | 36.59TCr | |
| Weighted average by Cap. | -0.48% | -3.46% | +38.66% | +65.51% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.56Cr 3.93Cr 3.68Cr 3.36Cr 6.33Cr 435.58Cr 6.35Cr 44Cr 17Cr 219.88Cr 17Cr 17Cr 729.08Cr | 5.39Cr 4.64Cr 4.35Cr 3.98Cr 7.49Cr 515.17Cr 7.51Cr 52Cr 20Cr 260.06Cr 20Cr 20Cr 862.3Cr |
| Net income | -5.32Cr -4.58Cr -4.3Cr -3.92Cr -7.39Cr -508.25Cr -7.41Cr -51Cr -20Cr -256.56Cr -20Cr -20Cr -850.72Cr | -5.19Cr -4.47Cr -4.19Cr -3.83Cr -7.21Cr -495.93Cr -7.23Cr -50Cr -19Cr -250.34Cr -19Cr -19Cr -830.1Cr |
| Net Debt | -7.3Cr -6.29Cr -5.9Cr -5.38Cr -10Cr -697.8Cr -10Cr -70Cr -27Cr -352.24Cr -27Cr -27Cr -1.17TCr | -3.21Cr -2.77Cr -2.59Cr -2.37Cr -4.46Cr -306.9Cr -4.48Cr -31Cr -12Cr -154.92Cr -12Cr -12Cr -513.69Cr |
Employees
18
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | SEK 1.810 | +0.56% | 1,02,699 |
| 27/26/27 | SEK 1.800 | +2.27% | 52,304 |
| 26/26/26 | SEK 1.760 | -7.37% | 1,77,342 |
| 25/26/25 | SEK 1.900 | +2.70% | 1,530 |
| 24/26/24 | SEK 1.850 | -0.54% | 61,865 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- ENZY Stock
Select your edition
All financial news and data tailored to specific country editions
